Product Images Zolmitriptan

This is a figure showing the estimated probability of achieving initial headache response within 4 hours of treatment in pooled Studies 2, 3, and 5 using different doses of Zolmitriptan and a placebo. The reduction in headache severity from moderate or severe pain to mild or no headache is represented as a percentage on the y-axis, and the time from initial dose is shown on the x-axis. The figure suggests that Zolmitriptan at doses of 1mg and 2.5mg has a higher probability of achieving initial headache response than the placebo, but Zolmitriptan at a dose of 5mg has the highest probability of achieving initial headache response.*

This is a prescription drug label for Zolmitriptan Tablets, USP, distributed by Aurobindo Pharma USA, Inc. The drug is manufactured in India. The label includes the drug's National Drug Code and dosage information. The remaining text is illegible or uninterpretable.*

This is a product information label for Zolmitriptan Tablets, USP containing 5 mg Zolmitriptan in a film-coated tablet form. The label includes dosage information and storage guidelines. It also warns to keep the medication out of reach of children and to use child-resistant containers for outpatient use. The manufacturer is Aurobindo, and the product is sold as a unit-dose package consisting of three tablets per package. The label's authenticity or completeness cannot be verified and as such, should not be used to make medication decisions.*